Search

Your search keyword '"Lin, Lie"' showing total 862 results

Search Constraints

Start Over You searched for: Author "Lin, Lie" Remove constraint Author: "Lin, Lie"
862 results on '"Lin, Lie"'

Search Results

1. Acoustic diagnostics of femtosecond laser filamentation

2. Nanotips for 0.5THz scattering scanning near field microscopy

3. Analysis of laser polarization state on remote induced plasma luminescence characteristics of filament in air

4. Femtosecond Laser Filamentation in Atmospheric Turbulence

5. Coupled air lasing gain and Mie scattering loss: aerosol effect in filament-induced plasma spectroscopy

6. Remote Sensing of Trace Element in Sea Salt Aerosol with Sensitivity Level of 10 pg/m3

7. Filament based Ionizing Radiation Sensing Technology

8. Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors

9. Sub-ppb aerosol detection at a distance of 30 meters by millijoule femtosecond laser pulse filamentation in air

16. Validation of the imatinib-therapy failure model

17. Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study

19. Spectral Domain Z-scan Technique

23. Landscape of Concomitant Driver Alterations in Classical EGFR -Mutated Non–Small Cell Lung Cancer.

24. A phase 2 trial of orelabrutinib showing promising efficacy and safety in patients with persistent or chronic primary immune thrombocytopenia

32. Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors

33. Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study

40. S299: ORELABRUTINIB, AN IRREVERSIBLE INHIBITOR OF BRUTON’S TYROSINE KINASE, FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: RESULTS OF A RANDOMIZED, OPEN-LABEL PHASE II STUDY

41. BAG2 overexpression correlates with growth and poor prognosis of esophageal squamous cell carcinoma

45. Polo‐like kinase 1 inhibitor NMS‐P937 represses nasopharyngeal carcinoma progression via induction of mitotic abnormalities.

49. Acoustic Diagnostics of Femtosecond Laser Filamentation

Catalog

Books, media, physical & digital resources